Aller directement au contenu
HPB-ALL
Tissu
Peripheral blood
Maladie
Precursor T-cell acute lymphoblastic leukemia
Site métastatique
Peripheral blood (systemic T-ALL)
Synonymes
HPB/ALL, HPBALL, FCCH1018

Documents

HPB-ALL

Cell line · Référence du produit 302895

HPB-ALL est une lignée cellulaire issue d'une leucémie lymphoblastique aiguë à cellules T précurseurs humaines (LLA-T) établie à partir du sang périphérique d'un garçon japonais de 14 ans...

€430.00hors taxes et frais de port

Personnalisation / Recommandations

En stock
Lot
Recommandé (lot le plus récent)
  • CoA
1

01Informations générales

Description

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Tissu
Peripheral blood
Maladie
Precursor T-cell acute lymphoblastic leukemia
Site métastatique
Peripheral blood (systemic T-ALL)
Applications
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Synonymes
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Classification

Organisme
Humain
Sexe
Homme
Propriétés de croissance
Suspension
Niveau de biosécurité
1

03Caractéristiques

Morphologie
Lymphoblast-like
Type de cellule
T-cell
Temps de doublement
~50 hours

04Identifiants

Référence
HPB-ALL (Cytion catalog number 302895)
Numéro d'identification fiscale NCBI
9606
Cellosaurus
CVCL_1820

05Expression et sensibilité

Profil mutationnel
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Manipulation et culture

Milieu de culture
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Compléments alimentaires
Supplement the medium with 10% FBS
Réactif de dissociation
dilution
Repiquage
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Rapport de fractionnement
1 : 10 split
Densité de semis
3-5*10^5/ml
Renouvellement des fluides
Subculture : 2 times/week
Décongélation et mise en culture
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Contrôle qualité et cryoconservation

Milieu de congélation
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Conditions de stockage

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Conditions de livraison

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donateur

Âge du donneur
14 years
Origine ethnique
Japanese

10Détails du produit

Tableau de composition